Opioid manufacturers, distributors, and pharmacy chains have settled $50+ billion in landmark litigation; major cases are now final or legally effective, redirecting funds to...
Read more →
Mass tort settlements hit $79 billion in 2025, with 199,000 MDL cases awaiting resolution and novel litigation categories redefining corporate accountability.
Read more →
After preliminary court approval in June 2026, four major opioid manufacturers and pharmacy chains await final settlement authorization with $180 million at stake.
Read more →
Financial connections link RFK Jr.'s health agenda to vaccine litigation interests and mass tort lawyer enthusiasm.
Read more →
Consolidated litigation offers efficiency but critics say the system now prioritizes speed and predictability over individual justice.
Read more →
Supreme Court bars state courts from suing over Roundup labeling, shielding Monsanto from tens of thousands of pending cancer injury claims.
Read more →
Asbestos litigation faces a convergence of medical, legal, and procedural obstacles that can leave sick victims unable to prove exposure or causation before the...
Read more →
Disney will pay $50 million to settle a class action lawsuit over mandatory ESPN bundling that raised streaming costs for subscribers.
Read more →
Mass tort coalitions consolidate power in a handful of lead firms, accelerating settlements but raising questions about individual claimant representation.
Read more →
Kirkland & Ellis recruits experienced mass tort partners from Orrick as law firms compete fiercely for specialized litigation expertise in a booming market.
Read more →
A law professor's new book reveals how a sophisticated fraud scheme manufactured thousands of pelvic mesh lawsuits, shocking the mass tort world.
Read more →
A team of mass tort lawyers leaving Orrick for Kirkland shows how elite defense talent is consolidating — and why claimants should care.
Read more →
Litigation costs—including discovery, expert fees, and administration—consume 30 to 50 percent of modern tort settlements before claimants receive payment.
Read more →
Chevron's sanctions motions aim to penalize alleged procedural violations by plaintiffs' attorneys in Philadelphia paraquat cases.
Read more →
AI is cutting mass tort discovery costs by 50-70%, making lower-value cases profitable for funders and law firms to pursue.
Read more →
State courts are handling mass tort verdicts faster while federal MDLs accumulate tens of thousands of pending cases.
Read more →
Mass tort cases valued at $25 billion are reshaping 2026 litigation, from talc to GLP-1 drugs to military water contamination.
Read more →
A firm starting in Kansas City or Milwaukee cannot instantly compete with established coastal firms, so successful ones identify high-volume tort...
Read more →
A federal judge froze $5.6B in settlement proceeds after finding a law firm likely stole its funding partner's trade secrets.
Read more →
199,000 pending drug and device cases with $50+ billion at stake are forcing courts and manufacturers to confront mass tort litigation on an unprecedented...
Read more →